Norcliffe Capital
Europe, East Sussex, United Kingdom, Wadhurst'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.
Investor Profile
Norcliffe Capital has made 8 investments, with 3 in the past 12 months and 38% as lead.
Stage Focus
- Seed (50%)
- Series A (25%)
- Series Unknown (25%)
Country Focus
- United Kingdom (88%)
- United States (13%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Health Diagnostics
- Machine Learning
- Biopharma
- Manufacturing
- Hospital
- Medical Device
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.